Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1098009/000118518521000787/amgreat20200331_10q.htm
October 2023
October 2023
August 2023
May 2023
January 2023
September 2022
September 2022
August 2022
August 2022
August 2022
Document And Entity Information - shares | 9 Months Ended | |
---|---|---|
Mar. 31, 2020 | May 21, 2021 | |
Document Information Line Items | ||
Entity Registrant Name | America Great Health | |
Document Type | 10-Q | |
Current Fiscal Year End Date | --06-30 | |
Entity Common Stock, Shares Outstanding | 20,746,021,836 | |
Amendment Flag | false | |
Entity Central Index Key | 0001098009 | |
Entity Current Reporting Status | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Document Period End Date | Mar. 31, 2020 | |
Document Fiscal Year Focus | 2020 | |
Document Fiscal Period Focus | Q3 | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Interactive Data Current | No |
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1098009/000118518521000787/amgreat20200331_10q.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by America Great Health.
America Great Health's Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
America Great Health provided additional information to their SEC Filing as exhibits
Ticker: AAGH
CIK: 1098009
Form Type: 10-Q Quarterly Report
Accession Number: 0001185185-21-000787
Submitted to the SEC: Tue Jun 08 2021 4:58:10 PM EST
Accepted by the SEC: Tue Jun 08 2021
Period: Tuesday, March 31, 2020
Industry: Pharmaceutical Preparations